NCT00709761 Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC Status COMPLETED Phase PHASE2
NCT00708292 A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma. Status COMPLETED Phase PHASE1/PHASE2
NCT00704678 Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis Status COMPLETED Phase PHASE2
NCT00704483 Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis Status COMPLETED Phase PHASE2
NCT00702052 Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy Status COMPLETED Phase PHASE2
NCT00700271 Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day Status COMPLETED Phase PHASE4
NCT00699296 Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma Status TERMINATED Phase PHASE2
NCT00699192 Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00698646 Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. Status COMPLETED Phase PHASE4
NCT00698464 Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function Status COMPLETED Phase PHASE1
NCT00690430 Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease Status COMPLETED Phase PHASE3
NCT00688909 Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer Status COMPLETED Phase PHASE4
NCT00688753 RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe Status COMPLETED Phase PHASE2
NCT00688623 RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe Status COMPLETED Phase PHASE2
NCT00687973 Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg Status COMPLETED Phase PHASE4
NCT00680901 LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib Status COMPLETED Phase PHASE3
NCT00680498 Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment Status COMPLETED Phase PHASE4
NCT00677092 Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis Status COMPLETED Phase PHASE2
NCT00674102 An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1